- Home
- BTI vs BMY Comparison
BTI vs BMY Comparison
Compare BTI & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTI
- BMY
- Stock Information
- Founded
- BTI 1902
- BMY 1887
- Country
- BTI United Kingdom
- BMY United States
- Employees
- BTI N/A
- BMY N/A
- Industry
- BTI Medicinal Chemicals and Botanical Products
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- BTI Health Care
- BMY Health Care
- Exchange
- BTI Nasdaq
- BMY Nasdaq
- Market Cap
- BTI 97.7B
- BMY 97.6B
- IPO Year
- BTI N/A
- BMY N/A
- Fundamental
- Price
- BTI $48.38
- BMY $46.99
- Analyst Decision
- BTI Strong Buy
- BMY Hold
- Analyst Count
- BTI 1
- BMY 16
- Target Price
- BTI N/A
- BMY $58.33
- AVG Volume (30 Days)
- BTI 6.7M
- BMY 14.2M
- Earning Date
- BTI 02-13-2025
- BMY 07-31-2025
- Dividend Yield
- BTI 6.21%
- BMY 5.29%
- EPS Growth
- BTI N/A
- BMY N/A
- EPS
- BTI 1.70
- BMY 2.67
- Revenue
- BTI $32,383,539,681.00
- BMY $47,636,000,000.00
- Revenue This Year
- BTI $1.68
- BMY N/A
- Revenue Next Year
- BTI $2.92
- BMY N/A
- P/E Ratio
- BTI $27.92
- BMY $17.57
- Revenue Growth
- BTI N/A
- BMY 4.62
- 52 Week Low
- BTI $31.35
- BMY $39.35
- 52 Week High
- BTI $49.58
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- BTI 57.89
- BMY 44.17
- Support Level
- BTI $46.38
- BMY $46.32
- Resistance Level
- BTI $47.56
- BMY $48.26
- Average True Range (ATR)
- BTI 0.57
- BMY 0.90
- MACD
- BTI -0.31
- BMY -0.01
- Stochastic Oscillator
- BTI 55.00
- BMY 17.48
About BTI British American Tobacco Industries p.l.c. ADR
The second-largest tobacco company by volume, British American Tobacco sold 505 billion cigarettes in 2024. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the us. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 25.5% stake in ITC limited, the largest Indian cigarette company.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.